The International Trade Commission is asking for comments by about Sept. 25 on a Sept. 10 patent complaint filed on behalf of South Alabama Medical Science Foundation, Merck & Cie, and Pamlab LLC, which alleges violations of Section 337 of the Tariff Act of 1930 in the import into the U.S., the sale for import, and the sale within the U.S. after import of certain reduced folate nutraceutical products and L-Methylfolate raw ingredients used therein (D/N 2912). The complaint names as respondents Gnosis SpA of Italy; Gnosis Bioresearch SA of Switzerland; Gnosis USA Inc. of Pa.; and Macoven Pharmaceuticals LLC of Texas. ITC is asking for comments on any public interest issues that might affect ITC consideration, including whether the issuance of an exclusion order and/or cease and desist order would impact the public interest.
The International Trade Administration published notices in the Sept. 14 Federal Register on the following AD/CV proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):
The International Trade Administration issued the preliminary results of its administrative review of the antidumping duty order on uncovered innerspring units from China (A-570-928) for one company, Tai Wa Hong. The ITA preliminarily determined that Tai Wa Hong failed to cooperate in the review, and so assigned it an adverse facts available (AFA) rate of 234.51 percent. According to the ITA's issues and decision memo in the IAACCESS database, Tai Wa Hong is a Macau company that failed to respond to the ITA's questionnaires. Because the company is not in China for the ITA's purposes, it assigned the company its own AFA rate rather than the China-wide rate. These preliminary results are not in effect. The ITA may modify them in the final results of this review and change the estimated AD cash deposit rate for this company.
On Sept. 13 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration extended to Oct. 25 the deadline for comments on the proposed information collection related to the proposed Unique Device Identification System. Comments on the information collection were originally due Sept. 10. General comments on the Unique Device Identification System proposed rule are still due by Nov. 7.
The Food and Drug Administration said it is refusing admission of Daniella brand mangoes from Mexico after FDA testing found salmonella in mangoes produced by Agricola Daniella, a mango supplier with multiple plantations and a single packing house located in Sinaloa, Mexico. A salmonella outbreak associated with the mangoes has infected 105 people in 16 states, it said.
On Sept. 13 the Foreign Agricultural Service issued the following GAIN reports:
The Food Safety and Inspection Service revised export requirements and plant lists for the following countries for Sept. 7-13.
The Codex Committee on Residues of Veterinary Drugs in Foods is inviting member countries and observer organizations to participate in a working group to prepare a discussion paper and project document for new work on guidelines for the establishment of Maximum Residue Limits (MRLs) or other residue limits of veterinary medicines in honey. The goal of the working group is to have several rounds of comments, with the final document to be circulated by the Codex Secretariat by the end of April 2013. Member countries and observer organizations interested in participating in the working group should provide the name(s), official title, and email address of their representative(s) to Dr. Jack Kay (j.kay@vmd.defra.gsi.gov.uk) by Oct. 15.
The Foreign Trade Zones Board issued the following notices for Sept. 14: